IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 388 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $9,000 | -18.2% | 200 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | -71.1% | 200 | -69.0% | 0.00% | – |
Q1 2020 | $38,000 | 0.0% | 646 | 0.0% | 0.00% | – |
Q4 2019 | $38,000 | +245.5% | 646 | +213.6% | 0.00% | – |
Q3 2019 | $11,000 | -8.3% | 206 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | -25.0% | 206 | 0.0% | 0.00% | – |
Q1 2019 | $16,000 | +45.5% | 206 | -6.8% | 0.00% | – |
Q4 2018 | $11,000 | +10.0% | 221 | +10.5% | 0.00% | – |
Q3 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q1 2018 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2017 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q3 2017 | $10,000 | -65.5% | 200 | -72.4% | 0.00% | – |
Q2 2017 | $29,000 | 0.0% | 724 | 0.0% | 0.00% | – |
Q1 2017 | $29,000 | -12.1% | 724 | +2.0% | 0.00% | – |
Q4 2016 | $33,000 | +32.0% | 710 | 0.0% | 0.00% | – |
Q3 2016 | $25,000 | -34.2% | 710 | -58.5% | 0.00% | – |
Q2 2016 | $38,000 | +850.0% | 1,710 | +1454.5% | 0.00% | – |
Q1 2016 | $4,000 | -33.3% | 110 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | – | 110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |